留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

应中央军委要求,2022年9月起,《药学实践杂志》将更名为《药学实践与服务》,双月刊,正文96页;2023年1月起,拟出版月刊,正文64页,数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿!

反相高效液相色谱法同时测定大鼠血浆中紫杉醇硬脂酸酯及其活性代谢产物紫杉醇的含量

程丹 陈建明

程丹, 陈建明. 反相高效液相色谱法同时测定大鼠血浆中紫杉醇硬脂酸酯及其活性代谢产物紫杉醇的含量[J]. 药学实践与服务, 2018, 36(3): 224-227,273. doi: 10.3969/j.issn.1006-0111.2018.03.007
引用本文: 程丹, 陈建明. 反相高效液相色谱法同时测定大鼠血浆中紫杉醇硬脂酸酯及其活性代谢产物紫杉醇的含量[J]. 药学实践与服务, 2018, 36(3): 224-227,273. doi: 10.3969/j.issn.1006-0111.2018.03.007
CHENG Dan, CHEN Jianming. Simultaneous determination of paclitaxel-stearate (PTX-SA)and its bioactive metabolite paclitaxel (PTX)by RP-HPLC[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(3): 224-227,273. doi: 10.3969/j.issn.1006-0111.2018.03.007
Citation: CHENG Dan, CHEN Jianming. Simultaneous determination of paclitaxel-stearate (PTX-SA)and its bioactive metabolite paclitaxel (PTX)by RP-HPLC[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(3): 224-227,273. doi: 10.3969/j.issn.1006-0111.2018.03.007

反相高效液相色谱法同时测定大鼠血浆中紫杉醇硬脂酸酯及其活性代谢产物紫杉醇的含量

doi: 10.3969/j.issn.1006-0111.2018.03.007

Simultaneous determination of paclitaxel-stearate (PTX-SA)and its bioactive metabolite paclitaxel (PTX)by RP-HPLC

  • 摘要: 目的 建立同时测定大鼠血浆中紫杉醇硬脂酸酯(PTX-SA)及其活性代谢产物紫杉醇(PTX)含量的RP-HPLC分析方法。 方法 以地西泮作为内标,采用液-液萃取法,用甲基叔丁基醚萃取血浆中药物。以乙腈-甲醇-水作为流动相进行梯度洗脱,紫外检测波长227 nm,柱温30℃,流速1 ml/min,进样量20 μl。 结果 大鼠血浆中PTX-SA和PTX在质量浓度分别为0.5~250和0.05~25 μg/ml的范围内均呈现良好的线性关系,相关系数r分别为0.997 6和0.997 9;两者的最低定量限(LOQ)分别为0.15和0.05 μg/ml;平均提取回收率均大于90%,RSD均小于5%;PTX-SA和PTX的日内与日间精密度均小于5%。 结论 该方法简便快捷,准确度、精密度高,可用于药动学研究中PTX-SA和PTX的含量测定。
  • [1] Weaver BA. How Taxol/paclitaxel kills cancer cells[J]. Mol Biol Cell,2014,25(18):2677-2681.
    [2] Wang Y,Li X,Wang L,et al. Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery[J]. Int J Nanomed,2011,6:1497-1507.
    [3] Zhang J,Sun T,Liang L,et al. Drug promiscuity of P-glycoprotein and its mechanism of interaction with paclitaxel and doxorubicin[J]. Soft Matter,2014,10(3):438-445.
    [4] Duggett NA,Griffiths LA,Flatters SJL. Paclitaxel-induced painful neuropathy is associated with changes in mitochondrial bioenergetics,glycolysis,and an energy deficit in dorsal root ganglia neurons[J]. Pain,2017,158(8):1499-1508.
    [5] Yoon KJ,Qi J,Remack JS,et al. Development of an etoposide prodrug for dual prodrug-enzyme antitumor therapy[J]. Mol Cancer Ther,2006,5(6):1577-1584.
    [6] Seligson AL,Terry RC,Bressi JC,et al. A new prodrug of paclitaxel:synthesis of Protaxel[J]. Anticancer drugs,2001,12(4):305-313.
    [7] Potter PM,Wadkins RM. Carboxylesterases——detoxifying enzymes and targets for drug therapy[J]. Curr Med Chem,2006,13(9):1045-1054.
    [8] Sanghani SP,Quinney SK,Fredenburg TB,et al. Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis[J]. Clin Cancer Res,2003,9(13):4983-4991.
    [9] Choi SS,Chi BH,Chang IH,et al. Human neural stem cells overexpressing a carboxylesterase inhibit bladder tumor growth[J]. Mol Cancer Ther,2016,15(6):1201-1207.
    [10] Miwa M,Ura M,Nishida M,et al. Design of a novel oral fluoropyrimidine carbamate,capecitabine,which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue[J].Eur J Cancer,1998,34(8):1274-1281.
    [11] Sharma S,Lagisetti C,Poliks B,et al. Dissecting paclitaxel-microtubule association:quantitative assessment of the 2'-OH group[J]. Biochemistry,2013,52(13):2328-2336.
    [12] Bergman AM,Adema AD,Balzarini J, et al. Antiproliferative activity,mechanism of action and oral antitumor activity of CP-4126,a fatty acid derivative of gemcitabine,in in vitro and in vivo tumor models[J]. Invest New Drugs,2011,29(3):456-466
    [13] Ji J,Zhang L,Wang P,et al. Saturated free fatty acid,palmitic acid,induces apoptosis in fetal hepatocytes in culture[J]. Exp Toxicol Pathol,2005,56(6):369-376.
    [14] de Oliveira MA,Porto BL,Faria ID,et al. 20 years of fatty acid analysis by capillary electrophoresis[J]. Molecules,2014,19(9):14094-14113.
  • [1] 李丹, 戴贤春, 王芳珍, 陈奕含, 杨萍, 刘继勇.  HPLC-MS/MS测定当归六黄汤中4种不同成分的含量 . 药学实践与服务, 2024, 42(6): 248-252, 266. doi: 10.12206/j.issn.2097-2024.202305007
    [2] 陈炳辰, 佟达丰, 万苗, 闫飞虎, 姚建忠.  UPLC-MS/MS法测定小鼠血浆中紫杉醇脂肪酸酯前药及其药代动力学研究 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202404082
  • 加载中
计量
  • 文章访问数:  2832
  • HTML全文浏览量:  371
  • PDF下载量:  401
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-12-18
  • 修回日期:  2018-02-28

反相高效液相色谱法同时测定大鼠血浆中紫杉醇硬脂酸酯及其活性代谢产物紫杉醇的含量

doi: 10.3969/j.issn.1006-0111.2018.03.007

摘要: 目的 建立同时测定大鼠血浆中紫杉醇硬脂酸酯(PTX-SA)及其活性代谢产物紫杉醇(PTX)含量的RP-HPLC分析方法。 方法 以地西泮作为内标,采用液-液萃取法,用甲基叔丁基醚萃取血浆中药物。以乙腈-甲醇-水作为流动相进行梯度洗脱,紫外检测波长227 nm,柱温30℃,流速1 ml/min,进样量20 μl。 结果 大鼠血浆中PTX-SA和PTX在质量浓度分别为0.5~250和0.05~25 μg/ml的范围内均呈现良好的线性关系,相关系数r分别为0.997 6和0.997 9;两者的最低定量限(LOQ)分别为0.15和0.05 μg/ml;平均提取回收率均大于90%,RSD均小于5%;PTX-SA和PTX的日内与日间精密度均小于5%。 结论 该方法简便快捷,准确度、精密度高,可用于药动学研究中PTX-SA和PTX的含量测定。

English Abstract

程丹, 陈建明. 反相高效液相色谱法同时测定大鼠血浆中紫杉醇硬脂酸酯及其活性代谢产物紫杉醇的含量[J]. 药学实践与服务, 2018, 36(3): 224-227,273. doi: 10.3969/j.issn.1006-0111.2018.03.007
引用本文: 程丹, 陈建明. 反相高效液相色谱法同时测定大鼠血浆中紫杉醇硬脂酸酯及其活性代谢产物紫杉醇的含量[J]. 药学实践与服务, 2018, 36(3): 224-227,273. doi: 10.3969/j.issn.1006-0111.2018.03.007
CHENG Dan, CHEN Jianming. Simultaneous determination of paclitaxel-stearate (PTX-SA)and its bioactive metabolite paclitaxel (PTX)by RP-HPLC[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(3): 224-227,273. doi: 10.3969/j.issn.1006-0111.2018.03.007
Citation: CHENG Dan, CHEN Jianming. Simultaneous determination of paclitaxel-stearate (PTX-SA)and its bioactive metabolite paclitaxel (PTX)by RP-HPLC[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(3): 224-227,273. doi: 10.3969/j.issn.1006-0111.2018.03.007
参考文献 (14)

目录

    /

    返回文章
    返回